Reply to "Does MAFLD really increase the severity of COVID-19?".
作者信息
Pan Lu, Huang Pan, Xie Xia, Xu Jiachen, Guo Dawei, Jiang Yuan
机构信息
Department of Critical Care Unit, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, No. 3002, Sungang west Road, Futian District, Shenzhen, China.
College of Nursing, Gannan Medical University, No. 1 Hexie Road, Rongjiang New area, Ganzhou, China.
出版信息
Dig Liver Dis. 2021 Feb;53(2):168. doi: 10.1016/j.dld.2020.10.034. Epub 2020 Nov 4.
Abstract
摘要
相似文献
1
Reply to "Does MAFLD really increase the severity of COVID-19?".对《MAFLD真的会增加COVID-19的严重程度吗？》的回复。
Dig Liver Dis. 2021 Feb;53(2):168. doi: 10.1016/j.dld.2020.10.034. Epub 2020 Nov 4.
2
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis.代谢相关脂肪性肝病增加 COVID-19 的严重程度：一项荟萃分析。
Dig Liver Dis. 2021 Feb;53(2):153-157. doi: 10.1016/j.dld.2020.09.007. Epub 2020 Sep 17.
3
COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD.COVID-19 大流行：对 SARS-CoV-2 感染与 MAFLD 之间相互作用的深入了解。
Int J Biol Sci. 2022 Jul 11;18(12):4756-4767. doi: 10.7150/ijbs.72461. eCollection 2022.
4
MAFLD in COVID-19 patients: an insidious enemy.COVID-19 患者中的 MAFLD：一个隐而难测的敌人。
Expert Rev Gastroenterol Hepatol. 2020 Oct;14(10):867-872. doi: 10.1080/17474124.2020.1801417. Epub 2020 Aug 4.
5
Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.血清白细胞介素-6 水平与 2019 年严重冠状病毒病患者代谢功能障碍相关脂肪性肝病的相关性和相互作用。
Front Endocrinol (Lausanne). 2021 Mar 8;12:604100. doi: 10.3389/fendo.2021.604100. eCollection 2021.
6
Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19.代谢功能障碍相关脂肪性肝病增加了严重新型冠状病毒肺炎的风险。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):825-827. doi: 10.1016/j.dsx.2020.06.013. Epub 2020 Jun 10.
7
Does MAFLD really increase the severity of COVID-19?MAFLD真的会增加新冠病毒疾病（COVID-19）的严重程度吗？
Dig Liver Dis. 2021 Feb;53(2):166-167. doi: 10.1016/j.dld.2020.10.042. Epub 2020 Nov 11.
8
Metabolic-associated fatty liver disease is associated with severity of COVID-19.代谢相关脂肪性肝病与 COVID-19 的严重程度相关。
Liver Int. 2020 Sep;40(9):2160-2163. doi: 10.1111/liv.14575. Epub 2020 Jul 5.
9
Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.2019冠状病毒病在肥胖人群中的严重程度：代谢功能障碍相关脂肪性肝病成为焦点。
World J Gastroenterol. 2021 Apr 28;27(16):1738-1750. doi: 10.3748/wjg.v27.i16.1738.
10
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.新型冠状病毒肺炎与代谢相关脂肪性肝病的关系：当前证据概述。
Viruses. 2023 Apr 27;15(5):1072. doi: 10.3390/v15051072.
本文引用的文献
1
Does MAFLD really increase the severity of COVID-19?MAFLD真的会增加新冠病毒疾病（COVID-19）的严重程度吗？
Dig Liver Dis. 2021 Feb;53(2):166-167. doi: 10.1016/j.dld.2020.10.042. Epub 2020 Nov 11.
2
The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis.吸烟对新冠病毒疾病症状严重程度的影响：系统评价与荟萃分析
Pulm Med. 2020 Sep 8;2020:7590207. doi: 10.1155/2020/7590207. eCollection 2020.
3
The Novel Coronavirus Disease (COVID-19): A PRISMA Systematic Review and Meta-Analysis of Clinical and Paraclinical Characteristics.新型冠状病毒病（COVID-19）：临床和辅助检查特征的 PRISMA 系统评价和荟萃分析。
Biomed Res Int. 2020 Aug 14;2020:3149020. doi: 10.1155/2020/3149020. eCollection 2020.
4
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素：系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
5
Epidemiological Features of NAFLD From 1999 to 2018 in China.中国 1999 年至 2018 年非酒精性脂肪性肝病的流行病学特征。
Hepatology. 2020 May;71(5):1851-1864. doi: 10.1002/hep.31150.
6
Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis.2008 年至 2018 年中国非酒精性脂肪性肝病负担的意外快速增长：系统评价和荟萃分析。
Hepatology. 2019 Oct;70(4):1119-1133. doi: 10.1002/hep.30702.
7
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
8
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.非酒精性脂肪性肝病的患病率及危险因素：狄俄尼索斯营养与肝脏研究
Hepatology. 2005 Jul;42(1):44-52. doi: 10.1002/hep.20734.
Zotero 插件